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Abstract  27 
Mammalian embryos change shape dramatically upon implantation.   The cellular and 28 
molecular mechanism underlying this transition are largely unknown. Here, we show that this 29 
transition is directed by cross talk between the embryonic epiblast and the first extra-30 
embryonic tissue, the trophectoderm. Specifically, we show via visualisation of a Cdx2-GFP 31 
reporter line and pharmacologically mediated loss and gain of function experiments that the 32 
epiblast provides FGF signal that results in differential fate acquisition in the multipotent 33 
trophectoderm leading to the formation of a tissue boundary within the tissue.  The 34 
trophectoderm boundary becomes essential for its expansion into a multi-layered epithelium. 35 
Folding of this multi-layered trophectoderm induces spreading of the second extra-embryonic 36 
tissue, the primitive endoderm. Together, these events remodel the pre-implantation embryo 37 
into its post-implantation cylindrical shape. Our findings uncover how communication 38 
between embryonic and extra-embryonic tissues provides positional cues to drive shape 39 
change in mammalian development during implantation.  40 
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Introduction 62 
Before implantation, mammalian embryos consist of the embryonic epiblast and two 63 
extra-embryonic lineages, the trophectoderm (TE) and the primitive endoderm (PE) 64 
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organised into the hollow, spherical blastocyst. Upon implantation this simple structure 65 
becomes remodelled1-5, in the case of the mouse embryo, into the so-called egg cylinder3. 66 
During this period, the pluripotent epiblast polarises and forms a central lumen6 while 67 
maintaining its position relative to the extra-embryonic tissues.  68 
In the blastocyst, the TE is subdivided into polar TE, which covers the epiblast at the 69 
embryonic pole, and mural TE, which overlays the blastocyst cavity at the abembryonic 70 
pole7,8. During implantation development, the polar TE remains multipotent and gives rise to 71 
the extra-embryonic ectoderm (ExE)9, which will contribute to the embryonic part of the 72 
placenta 10. The mural TE, on the other hand, differentiates into primary trophoblast giant 73 
cells, which are necessary for embryo implantation11,12. Blastocysts reconstituted by injecting 74 
epiblasts into trophospheres formed from isolated mural TE cells, can develop into post-75 
implantation embryos13-15. Thus, the distinct behaviour of polar and mural TE has been 76 
proposed to result from differential signalling emanating from the epiblast 13-15.  77 
The epiblast expresses FGF ligands during implantation development16. It has been 78 
suggested that such FGF signalling is necessary for post-implantation TE development 79 
because the isolation and maintenance of trophoblast stem cells in culture depends upon 80 
FGF4 to sustain its multipotent character17. However, in addition to its role in trophoblast 81 
stem cell maintenance, FGF signalling is necessary for pre-implantation development18 as it 82 
controls primitive endoderm specification19-23. Specifically, FGF4 expressed by the ICM 83 
signals through FGFR1 and FGFR2 to promote and maintain the expression of primitive 84 
endoderm lineage markers24-26. Consequently, knock out mice for FGFR1,2 and FGF4 85 
display pre-implantation phenotypes due to impaired PE specification18,25-27 and so the role of 86 
FGF signalling in TE morphogenesis during implantation development has remained unclear.   87 
Here, we demonstrate that FGF ligands produced by the epiblast are necessary for 88 
maintenance of trophectoderm multipotency and the differential fate acquisition of polar and mural 89 
trophectoderm, which leads to the establishment of a tissue boundary at the polar/mural 90 
trophectoderm interface. We show that the formation of this tissue boundary is indispensable for 91 
embryogenesis as its inhibition leads to defective polar trophectoderm expansion into the extra-92 
embryonic ectoderm.  Last, we demonstrate that newly formed extra-embryonic ectoderm folds, 93 
resulting in cell shape changes driven spreading of the primitive endoderm. These results 94 
demonstrate how morphogenesis of the extra-embryonic tissues drive the remodelling of the 95 
mouse embryo during implantation.  96 
 97 
 98 
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Results 99 
Trophectoderm cell flow ceases upon implantation 100 
The pre-implantation blastocyst comprises three distinct tissues spatially distributed along the 101 
embryonic-abembryonic axis: the embryonic (Em) pole comprises the epiblast surrounded by 102 
the polar TE and the PE while the abembryonic (Ab) pole consists of the mural TE 103 
encompassing the blastocyst cavity (Figure 1a). Upon implantation, the spherically-shaped 104 
blastocyst transforms into the egg cylinder. During this process, the polar TE generates the 105 
extra-embryonic ectoderm (ExE). This is followed by formation of visceral endoderm (VE) 106 
from the PE and its spreading to cover both epiblast and ExE (Figure 1a-c). It is known that 107 
before its expansion, the polar TE exhibits a flow towards the mural TE, leading to an 108 
increase in mural TE cell population9,28-30. Since such a polar to mural flow of the TE is not 109 
compatible with expansion of the polar TE in the opposite direction to form the ExE, we 110 
hypothesised that the polar TE cell flow must be terminated to allow ExE formation. To test 111 
this hypothesis, we filmed developing blastocysts expressing Cdx2-GFP to visualise the TE 112 
at two developmental stages (Figure 1d-i, Supplementary Figure 1a-c, Supplementary Movie 113 
1-3). Analysis of individual cell behaviour in pre-implantation blastocysts revealed the polar 114 
to mural TE flow (Figure 1d-g, Supplementary Figure 1a, Supplementary Movie 1), which 115 
was terminated in implanting blastocysts (Figure 1h-j, Supplementary Figure 1b-c, 116 
Supplementary Movie 2-3). Interestingly, we noticed that as the polar to mural TE flow 117 
stopped, a gradient of Cdx2, indicative of TE potency31, became established with higher 118 
levels of Cdx2 on the polar side than on the mural side (Supplementary Figure 1b, 119 
Supplementary Movie3). This gradient of Cdx2 expression was evident only upon 120 
termination of the flow and not before implantation when the polar to mural TE flow was 121 
taking place (Supplementary Figure 1d). These results suggest that differential properties of 122 
polar and mural TE regulate polar TE cell flow during implantation. 123 
 124 
Trophectoderm tissue boundary forms during implantation 125 
We next sought to determine how the termination of the polar to mural TE flow is achieved. 126 
In various systems, cell populations with different fates and function become separated by the 127 
formation of tissue boundaries. These are characterised by high actomyosin contractility at 128 
the respective interface of the two populations to prevent cell mixing32-36. To investigate 129 
whether the differentiation within the TE results in the generation of such a boundary 130 
between polar and mural parts, we analysed the distribution of actomyosin during and after 131 
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termination of the flow. We found high actomyosin contractility at the interface between TE 132 
cells expressing Cdx2 at high and low levels (Figure 2a-b, Supplementary Figure 2).  133 
 134 
As cell-cell-junction angles are known to undergo a characteristic widening upon 135 
tissue boundary formation37, we measured the angles between cells at the putative boundary 136 
within the TE. This revealed how the angles between cell junctions increased as the entire 137 
boundary became linear (Figure 2c-d, Supplementary Movie 4). These results indicate that a 138 
tissue boundary becomes established between polar and mural parts of the TE when the 139 
blastocyst initiates its transformation into the egg cylinder. 140 
 141 
Polar trophectoderm expansion follows tissue boundary formation 142 
To determine the dynamics of polar/mural TE boundary formation and polar TE expansion to 143 
form the ExE, we filmed the development of blastocysts recovered from the mother at the 144 
time of implantation (E4.5). We observed that polar TE expansion occurred after tissue 145 
boundary formation (Figure 3a, Supplementary Movie 5). In support of this, we observed cell 146 
shape changes in the TE once cell-cell junction angles increased. Whereas in early implanting 147 
blastocysts, polar TE cells were squamous, they transformed first into cuboidal and then 148 
columnar cells exhibiting reduced apical cell area following the polar/mural TE boundary 149 
formation (Figure 3b-c, Supplementary Figure 3a-b). During the same developmental period, 150 
the density of polar TE cells increased (Supplementary Figure 3c). Upon acquisition of 151 
columnar shape, polar TE cells changed the orientation of their division planes (Figure 3d-f, 152 
Supplementary Movie 6). Before tissue boundary formation and for as long as the polar TE 153 
epithelium remained single-layered, these cells divided perpendicular to the Em/Ab axis of 154 
the embryo and parallel to the epithelial layer (Figure 3f, Supplementary Figure 3d, 155 
Supplementary Movie 2-4). In contrast, once the tissue boundary formed and the cells had 156 
acquired columnar morphology, they divided along their long axes and therefore parallel to 157 
the Em/Ab axis and perpendicular to the epithelial layer. This resulted in expansion of the 158 
polar TE into a multi-layered epithelium (Figure 3d-f, Supplementary Movie 6). These 159 
observations suggest that the formation of a polar/mural TE boundary correlates with 160 
expansion of the polar TE into the ExE during egg cylinder morphogenesis.  161 
 162 
FGF and actomyosin control tissue boundary formation 163 
It has been proposed that positional information provided by the epiblast might be 164 
responsible for the differentiation into polar and mural TE, because only the polar but not the 165 
 6
mural TE is in direct contact with the epiblast13,14,38. FGF signalling is necessary for the 166 
maintenance of trophoblast stem cell character and is active in the ExE, which forms from the 167 
polar TE in early post-implantation stages17,27,39. At the time of implantation, the epiblast 168 
expresses FGF ligands16,40,41, mainly FGF4 and FGF5 (Supplementary Figure 4a), while the 169 
TE expresses FGF receptors (FGFR1, 2)25,42,43. Therefore, we hypothesised that maintenance 170 
of Cdx2 expression in the polar TE at the time of implantation could be a response of the 171 
tissue to FGF signalling. To test this possibility, we first assessed the status of FGF signalling 172 
before and during implantation using p-ERK and p-AKT as a read out of its activity39,44. This 173 
revealed that FGF signalling was not active in the polar TE before implantation but showed 174 
restricted activation in the polar TE in implanting blastocysts (Figure 4a-b, Supplementary 175 
Figure 4b-c).  176 
 177 
To examine whether FGF signalling is indeed responsible for the maintenance of 178 
multipotency in the polar TE at implantation stages, we inhibited FGF signalling in ex-vivo 179 
cultured blastocysts through treatment with a specific FGF receptor inhibitor39 for 20 h 180 
(Figure 4c). This treatment gave us temporal control over FGF inhibition and avoided an 181 
effect on the earlier specification of PE18,21,25-27. Inhibition of FGF signalling resulted in the 182 
loss of Cdx2 expression in the polar TE (Supplementary Figure 4d) without affecting 183 
specification of PE, which was already formed by the time of treatment. To confirm the role 184 
of FGF in differentially affecting the polar and mural TE, we next recovered blastocysts at 185 
E3.5 and cultured them for 24h to the E4.5 stage before treating them with FGF for 24h. This 186 
revealed that the presence of FGF prevents mural TE differentiation as indicated by Cdx2 187 
expression levels (Supplementary Figure 5a-c). These results indicate that positional 188 
information from the epiblast in the form of FGF signalling is responsible for the 189 
maintenance of multipotency in the polar TE, evident from the appearance of a gradient in 190 
Cdx2 expression. 191 
 192 
Since we observed high actomyosin contractility at the interface of polar/mural TE 193 
and as FGF signalling is responsible for multipotency maintenance in the polar TE resulting 194 
in the appearance of a Cdx2 expression gradient in the TE, we next wished to determine 195 
whether actomyosin contractility and FGF signalling play a role in the formation of the 196 
boundary between polar and mural TE. To this end, we cultured E4.5 blastocysts for 20h in 197 
the presence of ROCK inhibitor or blebbistatin(-) to inhibit actomyosin contractility45 (Figure 198 
4c, Supplementary Figure 6a). Inhibition of actomyosin contractility resulted in significantly 199 
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narrowed angles of the cell-cell borders at the polar/mural TE interface indicative of 200 
defective boundary formation (Figure 4d-f, Supplementary Figure 6b-c), thus confirming the 201 
essential role of actomyosin contractility in this process. Similarly, inhibition of FGF 202 
signalling during the same developmental time window led to defective polar/mural TE 203 
boundary formation (Figure 4d-f). Together, these results indicate the necessity of FGF 204 
signalling from the epiblast to the polar TE for the formation of the tissue boundary between 205 
polar and mural TE.  206 
 207 
To understand the role of the mural/polar TE boundary in subsequent development, 208 
we perturbed its formation by inhibiting either FGF signalling or actomyosin contractility in 209 
implanting embryos and following their subsequent development. We found that inhibition of 210 
FGF signalling or actomyosin contractility led to failure of both the polar TE to expand to 211 
form the ExE and egg cylinder formation (Figure 4g-h, Supplementary Figure 6b,d)). These 212 
results indicate that formation of the polar/mural TE tissue boundary is a key step in 213 
blastocyst to egg cylinder morphogenesis (Figure 4i). 214 
 215 
Primitive endoderm morphogenesis  216 
During the final stage of the blastocyst to egg cylinder transformation, the PE differentiates 217 
into the VE, which will cover both the epiblast and the newly formed ExE (Figure 1a-c). To 218 
gain insight into this process, we analysed the behaviour of the PE at consecutive stages of 219 
implantation development in vivo and in vitro. We found that PE cells localised at the distal 220 
tip of the epiblast facing the blastocyst cavity displayed a cuboidal shape, which became 221 
columnar upon implantation while still confined to the distal tip (Figure 5a-b, Supplementary 222 
Figure 7a-b, Supplementary Figure 8, Supplementary Movie 7). However, as development 223 
progressed, PE cells changed shape again to become cuboidal, concomitant with their 224 
spreading over the epiblast and the expansion of the polar TE (Figure 5a-c, Supplementary 225 
Figure 7b, Supplementary Figure 8-9, Supplementary Movie 7). These results suggest that 226 
expansion of the polar TE and spreading of the PE/VE are coordinated events.  227 
  228 
During implantation development, the PE gives rise not only to the VE but also to the 229 
parietal endoderm46. The parietal endoderm migrates towards the mural TE with Reichert’s 230 
membrane acting as a substrate for its migration47. Since it is possible that parietal endoderm 231 
migration might also contribute to PE morphogenesis during implantation development, we 232 
examined the movement of parietal endoderm cells in implanting blastocysts (E4.5-E4.75). 233 
 8
We found that parietal endoderm migration is completed before the TE expands and the PE 234 
spreads over the epiblast (Figure 5d). These results strongly suggest that parietal endoderm 235 
migration is not involved in PE/VE morphogenesis. 236 
 237 
Immediately preceding egg cylinder formation, the PE covers only the epiblast and is 238 
not in contact with the polar TE (Figure 5a-b, Supplementary Figure 8,9). We hypothesised 239 
that the polar TE expansion into ExE might act as a substrate for migration of the PE to cover 240 
the ExE. This would require degradation of the Reichert’s membrane that encloses the distal 241 
half of the embryo forming a continuous membrane with the embryonic basement membrane 242 
(Figure 5e upper panel). However, we found that after spreading of the PE, the whole egg 243 
cylinder remained enclosed by the continuous embryonic and Reichert’s basement membrane 244 
(Figure 5e lower panel). Together, these observations suggest that active migration of PE 245 
cells is not required for egg cylinder formation.  246 
 247 
Trophectoderm folding results in egg cylinder formation 248 
To understand how the PE develops into the VE, which covers the entire embryo during egg 249 
cylinder formation, we performed live imaging of Lifeact-GFP transgenic embryos from an 250 
early post-implantation stage (E4.75). Analyses of our movies revealed that the VE spreads 251 
over the ExE concomitantly with the folding of the ExE (Figure 6a-f, Supplementary Figure 252 
8-1 0, Supplementary Movie 8-9). Examination of embryos developing in vivo and fixed 253 
immediately upon recovery demonstrated that ExE folding is followed by directional growth 254 
of the embryo towards the Ab pole of the blastocyst cavity, which results in filling of the 255 
previously hollow space (Supplementary Figure 9).  256 
 257 
Based on the above observations we hypothesised that ExE folding could be the 258 
driving force for VE morphogenesis. Specifically, we considered that ExE folding and 259 
embryo movement towards the Ab pole might lead to the development of stretching forces 260 
leading to cell shape driven spreading of the VE48. To test this hypothesis, we measured the 261 
orientation of the long axes of VE cells and found that, upon ExE folding, the most proximal 262 
cells of the VE became aligned with the proximo-distal axis of the embryo (Figure 6g, 263 
Supplementary Figure 9). These results suggest the possibility that the VE responds passively 264 
to tensile forces48-50 generated along the proximal-distal axis as a result of ExE invagination. 265 
 266 
 9
To test this possibility further, we sought to prevent the ExE folding, which requires apical 267 
constriction51 and so can be prevented using a ROCK inhibitor45. We found that ROCK 268 
inhibition applied from an early post-implantation stage (E4.75), resulted in failure of ExE 269 
invagination, VE spreading, and consequently egg cylinder formation (Figure 6h-i, 270 
Supplementary Figure 11a, Supplementary Movie 10). To exclude any contribution of active 271 
VE cell movement as it develops to cover the ExE, we inhibited Rac, which is indispensable 272 
for collective cell migration52,53, and filmed the subsequent development. Inhibition of Rac 273 
affected neither expansion of the VE to cover the epiblast and ExE nor egg cylinder 274 
formation (Supplementary Figure 11b), in accord with the phenotype of embryos that are 275 
Rac1 knock-out only in the VE52. Thus, the expansion of the VE appears to be a passive 276 
response to egg cylinder formation. 277 
 278 
Discussion 279 
In this study, we describe morphogenetic events driving the critical phase of mammalian 280 
embryo development that takes place during implantation. Our findings demonstrate an 281 
interplay between positional, chemical signals and physical cellular responses that leads to 282 
global tissue rearrangements as the mouse blastocyst transforms into the egg cylinder. 283 
Specifically, we describe how FGF signalling from the epiblast determines the fate of a 284 
subset of TE cells and subsequent morphogenesis that generates forces necessary for the 285 
spreading of the PE/VE to cover not only the epiblast but also the expanding ExE (Figure 6j).  286 
 287 
Here, we show that the first morphogenetic event during the blastocyst to egg cylinder 288 
transition is the formation of a tissue boundary between the polar and mural TE. Formation of 289 
this boundary prevents the flow of polar TE cells towards the mural region that occurs at pre-290 
implantation stages. Abrogation of the formation of the TE boundary shows that it is 291 
necessary for proper embryo development. Our results show that actomyosin contractility at 292 
the interface between the mural and polar TE is indispensable for tissue boundary formation. 293 
Such an increase in actomyosin contractility at the interface of differentially fated cells is a 294 
feature of tissue boundary formation in various model systems54. In the case of the 295 
polar/mural TE boundary, the localised increase of actomyosin contractility at the interface 296 
could either be a result of heterophilic adhesions 32,37 or repulsive cues generated by 297 
Ephrin/Eph signalling55,56. 298 
 299 
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 Numerous studies have described the role of FGF signalling in PE specification and 300 
in the maintenance of trophoblast stem cells17,18,21,25-27,41. However how FGF signalling 301 
instructs the peri-implantation morphogenesis of the TE has not previously been studied due 302 
to the pre-implantation phenotypes of FGF and FGFR knock-out embryos18,25,26. Here, we 303 
show that the TE tissue boundary forms in response to FGF signalling originating from the 304 
epiblast. Specifically, FGF ligands produced by the epiblast act as positional cues driving 305 
differential fate acquisition of the polar (undifferentiated) and mural (differentiated) TE. 306 
Importantly, whereas FGF signalling is indispensable for polar TE morphogenesis and 307 
multipotency maintenance upon implantation, it is dispensable for maintenance of the TE’s 308 
multipotent state in pre-implantation stages25,41. During pre-implantation development, TE 309 
multipotency is maintained by co-operation of Notch and Hippo pathways57-59. It will be 310 
important to identify the mechanisms controlling the switch from FGF-independent to FGF-311 
dependent maintenance of TE multipotency during peri-implantation development in future 312 
studies. 313 
 314 
Upon TE tissue boundary formation, polar TE cells change from squamous to 315 
columnar morphologies. Similar shape changes from squamous to columnar morphologies 316 
are evident in the PE during egg cylinder formation. This could result from cell crowding due 317 
to continuous cell proliferation in a restricted environment48,60. Polar TE cells divide in a 318 
confined area imposed upon them by the formation of the tissue boundary between 319 
themselves and the mural TE. The PE tissue increases its cell number while being confined to 320 
the distal site of the epiblast. Polar TE cell shape changes are followed by polarised cell 321 
divisions that both contribute to the formation of the double cell layer of the ExE. TE 322 
expansion is followed by PE spreading over the epiblast, during which the PE cells change 323 
their shape from columnar to cuboidal. These cell shape changes could be a result of 324 
stretching forces experienced by the PE during TE expansion and the movement of  the 325 
epiblast towards the abembryonic pole of the implanting blastocyst48. 326 
 327 
The final step of egg cylinder formation is orchestrated by invagination of the newly 328 
formed ExE, which is driven by apical constriction of ExE cells51. Apical constriction as a 329 
mechanism for tissue folding has been described in different models61-64. Here, folding is 330 
initiated by apical constriction only when the polar TE expands to form the ExE. The 331 
proliferation of polar TE during this process leads to an increased cell density, which 332 
correlates with an increase in pressure forces within epithelial tissues65. It has been reported 333 
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that mechanical signals regulate myosin II distribution and turnover during tissue 334 
morphogenesis and wound healing66-68. Thus, we hypothesise that initiation of ExE folding as 335 
a result of apical constriction might be regulated by mechanically mediated enrichment of 336 
myosin II through a mechano-transductive cascade.   337 
 338 
Our results demonstrate that ExE folding is followed by VE spreading over the ExE, 339 
which is necessary for the completion of the blastocyst to egg cylinder transition. We find 340 
that neither parietal endoderm migration nor active PE cell migration contribute to this 341 
process. Just as with the spreading of  PE over the epiblast, the spreading of VE over the ExE 342 
is probably driven by mechanically induced cell shape changes48. In this case, the force 343 
generating mechanism is the folding of the ExE, which results in the directional growth of the 344 
embryo towards the Ab pole9. In agreement, prevention of ExE folding by inhibition of apical 345 
constriction results in impaired egg cylinder formation and VE spreading.  346 
 347 
In summary, our results demonstrate that TE morphogenesis orchestrates the shape 348 
acquisition of the post-implantation mouse embryo during the blastocyst to egg cylinder 349 
transition. The fact that murine and primate embryos are similar in morphology to the time of 350 
implantation, when they begin to display differential behaviour of the TE 1-5, suggests that the 351 
different shapes of murine and primate post-implantation embryos might be attributed to TE 352 
peri-implantation morphogenesis. Future studies on TE morphogenesis in different species 353 
should shed light onto the role of the TE in the mechanisms that lead to the characteristic 354 
shapes of implantation embryos of different mammalian species. 355 
 356 
Methods 357 
 358 
Embryo Recovery and Culture 359 
In accordance with national and international guidelines, the mice used were kept in the 360 
animal facility. All experiments performed have been regulated by the Animals (Scientific 361 
Procedures) Act 1986 Amendment Regulations 2012 and additional ethical review by the 362 
University of Cambridge Animal Welfare and Ethical Review Body (AWERB). 363 
Experiments were authorised by the Home Office (Licence number: 70/8864). Upon any 364 
identification of health concern, mice were culled by cervical dislocation. Pre-implantation 365 
stage embryos from Cdx2-GFP transgenic or CD1 females mated with either Cdx2-GFP 366 
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transgenic, F1, MF1, or CD1 males were flushed from the uteri and cultured in KSOM. 367 
Peri-implantation and early post-implantation embryos from Pdgfra-GFP, Lifeact-GFP, E-368 
Cadherin-GFP, Cdx2-GFP, and CD1 females mated with either Pdgfra-GFP, LIFEACTT-369 
GFP, E-Cadherin-GFP, Cdx2-GFP, F1, MF1, and CD1 males were dissected from the uteri 370 
or deciduas and cultured in drops of  Advanced DMEM/F12 (GIBCO) containing 20% FBS 371 
and supplemented with 2 mM L-glutamine (GIBCO), 1 mM sodium pyruvate (GIBCO), 372 
penicillin (25 units/ml)/streptomycin (25 μg/ml) (GIBCO), 1 × ITS-X (Invitrogen). The 373 
medium drops were covered with mineral oil and the embryos were cultured at 37ºC and 374 
5% CO2.  375 
For ROCK inhibition, the embryos were placed in drops of medium, either containing Y-376 
27632 ROCK inhibitor (100 μM) dissolved in DMSO or solely DMSO as a control and 377 
incubated 20 hours for examination of tissue boundary formation and 12 hours for 378 
examination of ExE folding at the above described conditions. For blebbistatin(-) 379 
treatment, the embryos were placed in drops of medium, either containing 50 μM 380 
blebbistatin(-)  dissolved in DMSO or solely DMSO as a control and incubated 20 hours 381 
for examination of tissue boundary formation at the above described conditions. For FGF 382 
treatment, embryos were recovered at E3.5 cultured for 24h in KSOM and then cultured for 383 
another 24h in IVC medium in the presence or the absence of 1000ng/ml Fgf4 + 1ug/ml 384 
Heparin FGFR inhibition was achieved through incubation of blastocysts in medium 385 
containing SU5402 at 40 μM or DMSO for the control group. For Rac inhibition, Rac1 386 
Inhibitor II, Z62954982 at a concentration of 100 μM was used and embryos for the control 387 
group were incubated in the same amount of DMSO.  388 
Generation of endogenous E-Cadherin-GFP transgenic mouse line 389 
A Cdh1-EGFP allele was created by inserting a loxP-stop-loxP-EGFP cassette immediately 390 
prior to the endogenous stop codon in the final exon of the Cdh1 gene 391 
(ENSMUSE00000469626; Chromosome 8: 106,668,613). The allele was designed that 392 
following Cre recombination the stop codon was removed and the EGFP open reading frame 393 
was fused to the coding sequence of the Cdh1 gene creating a Cdh1-EGFP fusion protein.  394 
Prior to Cre recombination the loxP sites are separated by 300bp spacer sequence composed 395 
of non-coding sequence from the human Pgk1 gene. 396 
The targeting vector was assembled as follows. Two synthetic DNA fragments (MWG 397 
Eurofins) were ligated to form a combined fragment comprising 5’ (300bp) and 3’ (500bp) 398 
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Cdh1 homology arms flanking a loxP-STOP-loxP element immediately adjacent to the last 399 
amino acid codon of Cdh1, an EGFP open reading frame and a FRT site within the sequence 400 
of the Cdh1 3’ UTR. 401 
An FRT-Hygro-R cassette was inserted into the above plasmid by co-transfection into EL250 402 
E.coli 69which express Flp recombinase under arabinose induction.  403 
The DNA fragment bound by the homology arms was excised and recombined69 into a pool 404 
of mouse genomic DNA BAC clones (Source Biosciences) carrying the mouse Cdh1 gene in 405 
EL250 E.coli70. 406 
A retrieval plasmid was generated by cloning a retrieval fragment (comprising 540bp and 490 407 
bp homology arms separated by a SwaI site) into NotI-AscI linearised pFlexDTA (a modified 408 
version of pFlexible)71. Following linearization by SwaI, the modified sequences were 409 
retrieved from BAC clones in EL250 E.coli by recombining. The retrieved plasmid 410 
represents the targeting vector with approximately 5kb and 4.5kb homology arms. 411 
The targeting vector was linearised by AscI digestion and transfected into HM1 mESCs72. 412 
Cells were selected under hygromycin (150ug/ml) and surviving colonies picked and 413 
screened for targeting by long range PCR (using the Roche Expand Long Template PCR 414 
System) from within the STOP element or hygromycin-resistance cassette to sequences 415 
beyond the ends of the homology arms. Oligo sequences used to screen cells to ensure 416 
appropriate targeting of the Cdh1 gene were TACCACGTGGATACCCCAAG and 417 
AGGTATGCCAGAAGCCACAG for the 5’ side and GTCCGAGGGCAAAGGAATAG and 418 
GAAGCCTCAGGTTTGGTTCC for the 3’ side.   419 
Following identification of correctly targeted clones, mouse lines were derived by injection 420 
of ES cells into C57BL/6J blastocysts. After breeding of chimeras, germline offspring were 421 
identified by coat colour and the presence of the modified allele was confirmed with the 3’ 422 
loxP primers described above.  Mice were subsequently crossed with a mouse line expressing 423 
Flpe (Tg(ACTFLPe)9205Dym) to delete the selectable marker by recombination at the FRT 424 
sites73. 425 
 426 
Immunostaining 427 
Embryos were fixed directly following dissection in 4% paraformaldehyde (PFA) in PBS for 428 
20 min at room temperature (RT). Incubation except fixation was carried out in wells coated 429 
with filtered FCS to avoid attachment of peri-implantation stages at the bottom of the wells. 430 
Permeabilisation was carried out for 20 min at RT through incubation in 0.3% Triton X-100 / 431 
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0.1M Glycin in PBS. Primary antibodies were prepared in blocking solution (0.1% Tween-20 432 
/ 10% filtered FCS in PBS) and incubated at 4ºC overnight. Secondary antibody incubation 433 
was performed at RT for 3h and carried out in blocking solution as well. Nuclear staining was 434 
incubated simultaneously with secondary antibodies using DAPI (10mg/ml). All washes were 435 
carried out in PBS supplemented with 0.1% Tween-20. For pERK staining, embryos were 436 
fixed in Methanol and incubated for 15 min at -20ºC in ice-cold Methanol. Following 437 
fixation, the embryos were stained as described above. Primary antibodies used: Cdx2 438 
(mouse monoclonal, 1:300, Launch Diagnostics, MU392-UC (Biogenex); E-Cadherin (rat, 439 
1:200, Thermo Fisher Scientific, 13-1900); Gata6 (goat, 1:200, R&D Systems, AF1700,); 440 
Laminin (rabbit, 1:300, Sigma, L9393); pAKT (rabbit, 1:100, Cell Signaling Technology, 441 
4060T), pERK (rabbit, 1:100, New England Biolabs, 4377T); phospho-Myosin Light chain II 442 
(rabbit, 1:100, Cell Signaling Technology, 3671S), podocalyxin (1:300; R&D systems, 443 
MAB1556). 444 
 445 
Secondary antibodies used: 446 
Alexa Fluor® 488 Phalloidin (1:500, Thermo Fisher Scientific, A12379); Alexa Fluor® 594 447 
Phalloidin (1:500, Thermo Fisher Scientific, A12381); Goat anti-Rat IgG (H+L) Secondary 448 
Antibody, Alexa Fluor 647 (donkey, 1:500, Thermo Fisher Scientific, A-21247); Alexa 449 
Fluor® 568 Donkey Anti-mouse IgG (donkey, 1:500, Thermo Fisher Scientific, A10037); 450 
Donkey anti-Mouse IgG (H+L) Secondary Antibody, Alexa Fluor® 488 (donkey, 1:500, 451 
Thermo Fisher Scientific, A-21202); Alexa Fluor 568 Donkey Anti-Rabbit IgG Antibody 452 
(donkey, 1:500, Thermo Fisher Scientific, A10042); Alexa Fluor® 647 Donkey Anti-Rabbit 453 
IgG (H+L) Antibody (donkey, 1:500, Thermo Fisher Scientific, A-31573); Alexa Fluor 647 454 
Donkey Anti-Mouse IgG (H L) Antibody (donkey, 1:500, Thermo Fisher Scientific; 455 
A31571); Donkey anti-Rat IgG (H+L) Secondary Antibody, Alexa Fluor® 488 conjugate 456 
(donkey, 1:500, Thermo Fisher Scientific, A-21208) 457 
 458 
Imaging 459 
Fixed embryos were imaged on a Leica SP8 microscope using a 63x oil objective. Pre-460 
implantation live blastocysts were imaged on a Spinning Disc 40x objective at a z-step size of 461 
1 μm. Implanting blastocysts as well as early post-implantation embryos were imaged on a 462 
Leica multiphoton SP8 microscope using a 25x water objective with a z-step size of 1 μm. 463 
For excitation, a 488 nm laser was used. Embryos transgenic for Cdx2-GFP, E-Cadherin-464 
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GFP, and Pdgfra-GFP were imaged with 1.5% of 488 nm laser. Embryos expressing LifeAct-465 
GFP were imaged at 0.25% of 488 nm laser.  466 
 467 
A detailed list of the reagents and equipment used for embryo mounting and culture to 468 
optimise live imaging is provided in the supplementary methods. A detailed protocol is 469 
uploaded in Nature protocol exchange (ref 74). 470 
 471 
 472 
Image processing and analysis 473 
Image analysis of fixed embryos was carried out using the Leica 3D viewer and Fiji. For 474 
single cell tracking, the Imaris image analysis software was used. Image processing was 475 
performed with the Fiji image processing software. 476 
 477 
Statistics and Reproducibility 478 
GraphPad Prism 6.0 software was used for all statistical analysis performed on the results 479 
obtained. For treatments, the embryos were allocated randomly to treatment and control 480 
group, but investigators were not blinded to group allocation. The sample size of the 481 
experiments carried out was defined based on previous experimental experience. Quantitative 482 
data presented, shows the mean ± s.e.m., percentages, or the total number of datapoints 483 
obtained. The statistical tests carried out on the quantitative data obtained are annotated in 484 
each figure legend. Except annotated otherwise, each experiment shown was carried out at 485 
least three times. 486 
  487 
Data availability 488 
The authors declare that all data supporting the findings of this study are available within the 489 
article and its supplementary information files or from the corresponding author upon 490 
reasonable request. 491 
 492 
 493 
The source data of Figures 1d, 1h, 1i, 2c, 3a, 3d, 5c, 6a, and Supplementary Figures S1b, S7a, 494 
S10c-d, S11a can be found as supplementary movies. The complete data supporting the 495 
results discussed in this study are available upon a reasonable request from the corresponding 496 
author. The source data underlying Figures 2d, 3b, 3c, 3f, 4f, 5b, 6b-g, and Supplementary 497 
Figures 3c, 5b, and 10c are provided as a Source Data file. 498 
 499 
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Figure legends 699 
Figure 1. Polar trophectoderm transformation. (a) Schematic for blastocyst to egg 700 
cylinder transformation. (b) Embryos at late pre-implantation blastocyst (E4.5) and early egg 701 
cylinder (E5.0-E5.25) stages stained for markers for primitive endoderm (PE)/visceral 702 
endoderm (VE) (Gata6) and trophectoderm (TE)/extra-embryonic ectoderm (ExE) (Cdx2). 703 
Representative of 20 embryos for each stage. (c) Embryo at peri-implantation stage (E4.75-704 
E5.0). Polar trophectoderm (pTE) expansion to form the ExE (red outline) precedes PE 705 
spreading (white outlines) during blastocyst to egg cylinder transition. Representative of 20 706 
embryos. (d) Stills from a time lapse movie of a Cdx2-GFP E3.5 blastocyst showing flow of 707 
cells from polar to mural TE. Cyan dots: tracking of individual cell nuclei. (e) Colour coded 708 
cell tracks according to number of generations as extracted after single cell tracking from 709 
Supplementary Movie 1 (d). Cyan dots: polar TE cells. Grey dots: mural TE cells. (f) 710 
Displacement map extracted after single cell tracking from Supplementary Movie 1 (d). (g) 711 
Polar TE displacement map extracted after single cell tracking from Supplementary Movie 1 712 
(d). (h) Stills from a time lapse movie of Cdx2-GFP E4.5 implanting blastocyst combined 713 
with the displacement map (magenta: polar TE; white: mural TE) showing stop of cell flow 714 
from polar to mural TE upon implantation. (i) Stills from a time lapse movie of Cdx2-GFP 715 
E4.5 implanting blastocyst combined with single cell tracking (magenta: polar TE; cyan: 716 
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mural TE) showing stop of cell flow from polar to mural TE upon implantation. (j) Model of 717 
polar TE cell flow in pre- and post- implantation blastocysts. Scale bars = 20um.  718 
 719 
Figure 2: Establishment of tissue boundary within the trophectoderm. (a) Maximum 720 
intensity projection (MIP) image of an implanted E4.75 blastocyst. Arrowheads indicate 721 
tissue boundary between polar and mural TE. Representative example of 20 embryos. (b) 722 
MIP image of an implanted E4.75 blastocyst. Arrowheads indicate actomyosin enrichment at 723 
the boundary between polar and mural TE. Representative example of 8 embryos. (c) Stills 724 
from a time lapse movie of Cdx2/E-Cad GFP E4.5 implanting blastocyst. Red line follows 725 
the boundary between high-Cdx2 cells (polar TE) and low-Cdx2 cells (mural TE). As 726 
development progresses, polar and mural TE cells segregate and a linear tissue boundary 727 
formed (arrowheads). (d) Quantification of cell-cell junction angle at the polar/mural TE 728 
boundary and within polar TE. Two-sided unpaired student’s t-test; ****P<0.0001; 729 
mean±SEM. n=56 polar/mural TE and 63 polar TE cell junctions. Source data are provided 730 
as a Source Data file. Scale bars=20um 731 
 732 
Figure 3: Cell shape changes and polarized cell divisions drive polar TE expansion 733 
(a) Stills from a time-lapse movie of Lifeact-GFP blastocyst. Red arrowheads indicate the 734 
polar/mural TE boundary. Boundary formation is followed by polar TE expansion. (b) 735 
Quantification of polar TE cell aspect ratio at different developmental stages. Two-sided 736 
unpaired student’s t-test; ****P<0.0001; mean±SEM. Pre-implantation blastocyst: n=216 737 
cells; Implanted blastocyst: n=152 cells; Transitioning blastocyst; n=75 cells. (c) 738 
Quantification of polar TE apical cell surface are. Two-sided unpaired student’s t-test; 739 
****P<0.0001; mean±SEM. Blastocyst before: n=186 cells; Transitioning blastocyst; n=163 740 
cells. (d) Stills from a time lapse movie of Lifeact-GFP implanted blastocyst. Polar TE 741 
expansion is evident at 2.5h upon polar TE cell shape changes and polarised cell division. (e) 742 
Representative examples of polar TE cells dividing parallel to 743 
Embryonic(Em)/Abembryonic(Ab) axis during polar TE expansion. (f) Rose diagram for 744 
quantification of cell division orientation in blastocysts before (green) and during (purple) 745 
polar TE expansion.  Kolmogorov-Smirnov test: ****p<0.0001. Blastocyst before polar TE 746 
expansion: n= 24, Bastocyst during polar TE expansion: n= 36. Source data are provided as a 747 
Source Data file.Scale bars= 20um. 748 
 749 
Figure 4. Tissue boundary is necessary for polar trophectoderm expansion. 750 
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 (a) Implanted blastocyst (E4.75) stained for phosphorylated ERK (pERK). pERK is detected 751 
in the primitive endoderm (PE) and the trophectoderm (TE). pERK is restricted to the polar 752 
region of the TE. (b) Implanted blastocyst (E4.75) stained for phosphorylated AKT (pAKT). 753 
pAKT is restricted to the polar region of the TE. For (a) and (b) representative example of 10 754 
embryos.  (c) Schematic representation of the experimental design to examine the 755 
contribution of actomyosin contractility and FGF signalling in the formation of polar/mural 756 
TE tissue boundary formation. (d) Representative examples of control, Y27632 (ROCK 757 
inhibitor) and SU5402 (Fgfr inhibitor) treated blastocysts cultured as described in (c) and 758 
analysed for the presence of polar/mural TE boundary (cyan dotted line). Polar/mural tissue 759 
boundary formation is defective in the absence of actomyosin contractility and FGF 760 
signalling. (e) Quantification of polar/mural TE boundary formation efficiency in control, 761 
Y27632 and SU5402 treated blastocysts. χ2 test ; ****P<0.0001, mean±SEM. For (d) and (e) 762 
FGF n= 29 control, 15 Y27632 treated and 15 SU5402 treated embryos. (f) Quantification of 763 
cell-cell junction angles at the polar/mural TE interface. The angles of junctions after 764 
abrogation of actomyosin contractility (Y27632) and signalling (SU5402) are narrowed in 765 
agreement with the defective formation of polar/mural TE tissue boundary in these 766 
conditions.  Two-sided unpaired student’s t-test; ****P<0.0001; mean±SEM. Control: n=57; 767 
Y27632: n=38; SU5402: n=45. (g) Representative examples of control, Y27632 (ROCK 768 
inhibitor) and SU5402 (FGFR inhibitor) treated blastocyst cultured as described in (b) and 769 
analysed for polar-TE (white outline) expansion. (h) Quantification polar TE expansion 770 
efficiency in control, Y27632 and SU5402 treated blastocysts. χ2 test ; ****P<0.0001. For (f) 771 
and (g) n= 29 control, 15 Y27632 treated and 15 SU5402 treated embryos. (i) Model for the 772 
molecular and cellular events necessary for polar TE expansion during peri-implantation 773 
morphogenesis. Source data are provided as a Source Data file. Scale bars= 20um 774 
 775 
Figure 5. Primitive endoderm behaviour during the blastocyst to egg cylinder 776 
transition. (a) Examples of embryos used for analysis of primitive endoderm (PE) cell shape 777 
at different stages of peri-implantation development. Representative of 20 embryos for each 778 
stage. (b) Quantification of PE cell aspect ratio at different developmental stages. The red 779 
lines between different columns correspond to events taking place within the trophectoderm 780 
(TE). Two-sided unpaired student’s t-test; ****P<0.0001; mean±SEM. Pre-implantation 781 
blastocyst: n=117 cells; Implanted blastocyst: n=219 cells; Transitioning blastocyst: n=117 782 
cells; early egg cylinder: n=184 cells. (c) Stills from a time lapse movie of Lifeact-GFP E4.5 783 
implanting blastocyst. PE (cyan) acquires a columnar morphology at implantation stages and 784 
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this is followed by tissue spreading through cell-shape changes upon polar-TE (red) 785 
expansion as quantified in (b). Red double-headed arrows: polar TE expansion. Cyan arrows: 786 
PE spreading. Stills without coloured overlay are presented in Supplementary Figure 7b. (d) 787 
Representative examples of implanting blastocyst (E4.5-E4.75). Parietal endoderm migration 788 
is completed before the expansion of the TE (double headed arrows in bottom row) and 789 
before PE (red outline in 2D images) spreading over the lateral sides of the epiblast (bottom 790 
row). Red arrows indicate the front of the migrating parietal endoderm. (e) Representative 791 
examples of transitioning blastocysts (E5.0) displaying expanded polar trophectoderm and 792 
early egg cylinders. Primitive endoderm cells are found enclosed between the embryonic and 793 
Reichert’s basement membrane during blastocyst to egg-cylinder transformation. arrowheads: 794 
Reichert’s membrane. Arrows: Embryonic basement membrane. Dots: Proximal cells. 795 
Representative images of 20 embryos per stage. Source data are provided as a Source Data 796 
file. Scale bars=20um 797 
 798 
 799 
Figure 6. Trophectoderm folding orchestrates the final step the blastocyst to egg 800 
cylinder transformation.  801 
(a) Stills from a time lapse movie of Lifeact-GFP blastocyst. ExE tissue (red) folding (white 802 
arrows) through apical constriction is followed by spreading (yellow arrows) of the visceral 803 
endoderm (VE) (yellow outline) and formation of egg cylinder. Stills without coloured 804 
overlay are presented in Supplementary Figure 10a. (b) Quantification of ExE apical cell 805 
surface area, VE apical cell surface area and VE length through time during blastocyst to egg 806 
cylinder transformation from 3 individual embryos shown in Supplementary Movie 8. Cyan 807 
boxes indicate the developmental period, during which ExE cell’s apical constriction 808 
precedes VE spreading. VE tissue spreading during egg cylinder formation is due to cell-809 
shape changes as quantified in Figure 5b. (c) Quantification of polar TE/ExE apical cell 810 
surface area relative to PE/VE position. (d) Quantification of PE/VE cell aspect ratio relative 811 
to PE/VE position. (e) Quantification of PE/VE cell aspect ratio relative to polar-TE/ExE 812 
apical cell surface area. (f) Quantification of polar TE/ExE cell aspect ratio relative to PE/VE 813 
cell aspect ratio.  For c-f, Pearson correlation test was used, ****p<0.0001. (g) Rose diagram 814 
for quantification of long cell axis orientation in distal and proximal VE at the early egg 815 
cylinder stage. Kolmogorov-Smirnov test: ****p<0.0001. Distal VE: n= 153 cells, Proximal 816 
VE: n= 75 cells.  (h) Representative examples of control and Y27632 (ROCK inhibitor) 817 
treated embryos. Embryos were recovered at E4.75 and cultured ex-vivo for 12 hours. In the 818 
 24
absence of actomyosin contractility (Y27632) egg cylinder formation fails due to defective 819 
ExE folding (Supplementary Movie 10). (i) Quantification of blastocyst to egg cylinder 820 
transformation efficiency in control, and Y27632 treated embryos. χ2 test ; ****P<0.0001. 821 
For (h) and (i) n=16 control and 29 Y27632 treated embryos. (j) Model of blastocyst to egg 822 
cylinder transformation as a result of TE morphogenesis. Source data are provided as a 823 
Source Data file. Scale bars=20um. 824 






